While the analysis on CRC did not demonstrate the significant correlation between p16 hypermethylation and DFS of patients (HR 2.11, 95% CI: 0.75–5.95) in a random-effects model (Figure 2D). The gene discussed is CDKN2A; the disease is colorectal carcinoma.